<p>Lazard Asset Management LLC 在最近向证券交易委员会提交的 13F 表格中披露，在第四季度将其在 Elanco Animal Health Incorporated (NYSE:ELAN - 免费报告) 的持仓增加了 644.3%。该基金在季度内购买了额外的 25,109 股后，持有该公司 29,006 股股票。根据其最新的 SEC 文件，Lazard Asset Management LLC 在 Elanco Animal Health 的持股价值为 350,000 美元。</p>
<p>获取 <strong>Elanco Animal Health</strong> 警报：</p>
<ul>
<li>看涨还是看跌？评估动物健康护理股票</li>
</ul>
<p>其他一些大型投资者最近也对该公司的持仓进行了调整。CoreCap Advisors LLC 在第四季度购买了价值 29,000 美元的 Elanco Animal Health 新股份。Jones Financial Companies Lllp 在第四季度将其在 Elanco Animal Health 的持股增加了 95.6%。Jones Financial Companies Lllp 目前持有该公司 4,212 股股票，价值 51,000 美元，此前在上个季度又购买了 2,059 股。SRS Capital Advisors Inc. 在第四季度将其在 Elanco Animal Health 的持股增加了 221.2%。SRS Capital Advisors Inc. 目前持有该公司 4,953 股股票，价值 60,000 美元，此前在上个季度又购买了 3,411 股。MRP Capital Investments LLC 在第四季度购买了价值约 61,000 美元的 Elanco Animal Health 新股份。最后，Blue Trust Inc. 在第四季度将其在 Elanco Animal Health 的持仓增加了 47.7%。Blue Trust Inc. 目前持有该公司 5,862 股股票，价值 71,000 美元，此前在此期间又收购了 1,894 股。机构投资者持有该公司 97.48% 的股票。</p>
<h2>分析师评级调整</h2>
<p>一些股票分析师最近对该股票进行了评论。摩根士丹利在 2 月 26 日的研究报告中将 Elanco Animal Health 的目标股价从 14.00 美元下调至 13.00 美元，并对该股票给予了 “持平” 的评级。瑞银集团在 2 月 26 日的报告中将 Elanco Animal Health 的目标股价从 18.00 美元下调至 17.00 美元，并对该股票给予了 “买入” 的评级。Stifel Nicolaus 在周一将 Elanco Animal Health 的目标股价从 15.00 美元上调至 16.00 美元，并给予该公司 “买入” 评级。巴克莱在 2 月 26 日的研究报告中将 Elanco Animal Health 的目标股价从 20.00 美元下调至 19.00 美元，并对该公司给予了 “超配” 的评级。最后，派珀桑德勒在 3 月 6 日的研究报告中将 Elanco Animal Health 的目标股价从 16.00 美元下调至 12.00 美元，并对该股票给予了 “中性” 评级。四位股票研究分析师对该股票给予了持有评级，三位给予了买入评级。根据 MarketBeat.com，该公司目前的共识评级为 “持有”，平均目标股价为 15.17 美元。</p>
<ul>
<li>Zoetis 宣布新股息，暗示被低估</li>
</ul>
<p><strong>查看我们关于 ELAN 的最新研究报告</strong></p>
<h2>Elanco Animal Health 的内部活动</h2>
<p>在相关消息中，董事 Lawrence Erik Kurzius 于 3 月 11 日星期二收购了 10,000 股该股票。该股票的平均收购成本为每股 10.20 美元，总交易额为 102,000.00 美元。交易完成后，该董事目前直接持有该公司 111,459 股股票，价值 1,136,881.80 美元。这笔交易代表了他们持股的 9.86% 增加。该交易已在与证券交易委员会的法律文件中披露，相关文件可通过此超链接获取。当前 0.89% 的股票由内部人士持有。</p>
<h2>Elanco Animal Health 的价格表现</h2>
<ul>
<li>2 只具有重大上行潜力的逆向股票推荐</li>
</ul>
<p>NYSE:ELAN 的股票在周五开盘价为 12.68 美元。该公司有 50 日移动平均线为 10.30 美元，200 日移动平均线为 11.46 美元。Elanco Animal Health Incorporated 的 12 个月低点为 8.02 美元，12 个月高点为 18.80 美元。该公司的流动比率为 2.55，速动比率为 1.31，债务与股本比率为 0.66。该股票的市值为 63 亿美元，市盈率为 31.70，市盈增长比率为 2.50，贝塔值为 1.49。</p>
<p>Elanco Animal Health (NYSE:ELAN - 获取免费报告) 最近于 5 月 7 日宣布了其季度财报。该公司报告季度每股收益为 0.37 美元，超出市场共识预期的 0.31 美元，超出幅度为 0.06 美元。Elanco Animal Health 的净利润率为 4.60%，股本回报率为 6.78%。该公司在本季度的收入为 11.9 亿美元，而市场共识预期为 11.7 亿美元。在去年同期，该公司每股收益为 0.34 美元。该公司的收入同比下降了 1.0%。平均而言，股票研究分析师预测 Elanco Animal Health Incorporated 在当前财年将发布 0.91 美元的每股收益。</p>
<h2>Elanco Animal Health 公司简介</h2>
<p>(免费报告)</p>
<p>Elanco Animal Health Incorporated 是一家动物健康公司，创新、开发、生产和销售宠物和农场动物的产品。它提供宠物健康疾病预防产品，如驱虫剂和疫苗产品，保护宠物免受蠕虫、跳蚤和蜱虫的侵害，品牌包括 Seresto、Advantage、Advantix 和 Advocate；针对犬猫的疼痛、骨关节炎、耳部感染、心血管和皮肤病等适应症的宠物健康治疗产品，品牌包括 Galliprant 和 Claro；用于家禽和水产养殖生产的疫苗、抗生素、驱虫剂及其他产品，以及营养健康产品，包括酶、益生菌和益生元；以及用于反刍动物和猪生产的一系列疫苗、抗生素、植入物、驱虫剂及其他产品，品牌包括 Rumensin 和 Baytril。</p>
<h2>精选故事</h2>
<ul>
<li>我们更看好的五只股票，而非 Elanco Animal Health</li>
<li>最佳 ESG 股票：11 只最佳 ESG 投资股票</li>
<li>Joby 股票的波动：近期下跌背后的原因是什么？</li>
<li>CD 计算器：定期存款计算器</li>
<li>为什么嘉年华可能是终极非科技增长股票</li>
<li>交易暂停解释</li>
<li>超微计算机股票因沙特订单而开辟新高的路径</li>
</ul>
<p><strong>想看看其他对 ELAN 感兴趣的对冲基金持有什么吗？</strong> 访问 HoldingsChannel.com 获取 Elanco Animal Health Incorporated (NYSE:ELAN - 免费报告) 的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMQU4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMQU4"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Elanco Animal Health 吗？</h2>
<p>在你考虑 Elanco Animal Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 Elanco Animal Health 并不在名单上。</p>
<p>虽然 Elanco Animal Health 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

ELAN

<p>Lazard Asset Management LLC 在第四季度将其在 Elanco Animal Health (NYSE:ELAN) 的持股增加了 644.3%，收购了 25,109 股，使其总持股达到 29,006 股，价值 350,000 美元。其他投资者也调整了他们的持仓，机构持股比例为 97.48%。分析师对该股票的评级意见不一，普遍评级为 “持有”，平均目标价为 15.17 美元。Elanco 的股票开盘价为 12.68 美元，12 个月的价格区间为 8.02 至 18.80 美元。该公司报告第一季度每股收益为 0.37 美元，超出预期</p>

<p>Lazard Asset Management LLC grew its position in Elanco Animal Health Incorporated (NYSE:ELAN - Free Report) by 644.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 29,006 shares of the company's stock after purchasing an additional 25,109 shares during the quarter. Lazard Asset Management LLC's holdings in Elanco Animal Health were worth $350,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Lazard Asset Management LLC 在最近向证券交易委员会提交的 13F 表格中披露，在第四季度将其在 Elanco Animal Health Incorporated (NYSE:ELAN - 免费报告) 的持仓增加了 644.3%。该基金在季度内购买了额外的 25,109 股后，持有该公司 29,006 股股票。根据其最新的 SEC 文件，Lazard Asset Management LLC 在 Elanco Animal Health 的持股价值为 350,000 美元。</p>
</div><p>Get <strong>Elanco Animal Health</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Elanco Animal Health</strong> 警报：</p>
</div><ul>
<li>Bullish or Bearish? Vetting Animal Health Care Stocks</li>
</ul>
<div class="lb-trans"><ul>
<li>看涨还是看跌？评估动物健康护理股票</li>
</ul>
</div><p>A number of other large investors also recently made changes to their positions in the company. CoreCap Advisors LLC bought a new stake in Elanco Animal Health in the 4th quarter valued at $29,000. Jones Financial Companies Lllp lifted its holdings in shares of Elanco Animal Health by 95.6% during the fourth quarter. Jones Financial Companies Lllp now owns 4,212 shares of the company's stock worth $51,000 after buying an additional 2,059 shares in the last quarter. SRS Capital Advisors Inc. lifted its holdings in shares of Elanco Animal Health by 221.2% during the fourth quarter. SRS Capital Advisors Inc. now owns 4,953 shares of the company's stock worth $60,000 after buying an additional 3,411 shares in the last quarter. MRP Capital Investments LLC bought a new stake in shares of Elanco Animal Health in the fourth quarter valued at about $61,000. Finally, Blue Trust Inc. boosted its position in shares of Elanco Animal Health by 47.7% in the fourth quarter. Blue Trust Inc. now owns 5,862 shares of the company's stock valued at $71,000 after acquiring an additional 1,894 shares during the period. Institutional investors own 97.48% of the company's stock.</p>
<div class="lb-trans"><p>其他一些大型投资者最近也对该公司的持仓进行了调整。CoreCap Advisors LLC 在第四季度购买了价值 29,000 美元的 Elanco Animal Health 新股份。Jones Financial Companies Lllp 在第四季度将其在 Elanco Animal Health 的持股增加了 95.6%。Jones Financial Companies Lllp 目前持有该公司 4,212 股股票，价值 51,000 美元，此前在上个季度又购买了 2,059 股。SRS Capital Advisors Inc. 在第四季度将其在 Elanco Animal Health 的持股增加了 221.2%。SRS Capital Advisors Inc. 目前持有该公司 4,953 股股票，价值 60,000 美元，此前在上个季度又购买了 3,411 股。MRP Capital Investments LLC 在第四季度购买了价值约 61,000 美元的 Elanco Animal Health 新股份。最后，Blue Trust Inc. 在第四季度将其在 Elanco Animal Health 的持仓增加了 47.7%。Blue Trust Inc. 目前持有该公司 5,862 股股票，价值 71,000 美元，此前在此期间又收购了 1,894 股。机构投资者持有该公司 97.48% 的股票。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级调整</h2>
</div><p>A number of equities analysts recently commented on the stock. Morgan Stanley lowered their price target on shares of Elanco Animal Health from $14.00 to $13.00 and set an &#34;equal weight&#34; rating on the stock in a research report on Wednesday, February 26th. UBS Group lowered their target price on shares of Elanco Animal Health from $18.00 to $17.00 and set a &#34;buy&#34; rating on the stock in a report on Wednesday, February 26th. Stifel Nicolaus lifted their price target on shares of Elanco Animal Health from $15.00 to $16.00 and gave the company a &#34;buy&#34; rating in a research report on Monday. Barclays cut their price target on Elanco Animal Health from $20.00 to $19.00 and set an &#34;overweight&#34; rating for the company in a research note on Wednesday, February 26th. Finally, Piper Sandler lowered their price objective on Elanco Animal Health from $16.00 to $12.00 and set a &#34;neutral&#34; rating on the stock in a research note on Thursday, March 6th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of &#34;Hold&#34; and an average price target of $15.17.</p>
<div class="lb-trans"><p>一些股票分析师最近对该股票进行了评论。摩根士丹利在 2 月 26 日的研究报告中将 Elanco Animal Health 的目标股价从 14.00 美元下调至 13.00 美元，并对该股票给予了 “持平” 的评级。瑞银集团在 2 月 26 日的报告中将 Elanco Animal Health 的目标股价从 18.00 美元下调至 17.00 美元，并对该股票给予了 “买入” 的评级。Stifel Nicolaus 在周一将 Elanco Animal Health 的目标股价从 15.00 美元上调至 16.00 美元，并给予该公司 “买入” 评级。巴克莱在 2 月 26 日的研究报告中将 Elanco Animal Health 的目标股价从 20.00 美元下调至 19.00 美元，并对该公司给予了 “超配” 的评级。最后，派珀桑德勒在 3 月 6 日的研究报告中将 Elanco Animal Health 的目标股价从 16.00 美元下调至 12.00 美元，并对该股票给予了 “中性” 评级。四位股票研究分析师对该股票给予了持有评级，三位给予了买入评级。根据 MarketBeat.com，该公司目前的共识评级为 “持有”，平均目标股价为 15.17 美元。</p>
</div><ul>
<li>Zoetis Declares New Dividend, Hinting At Undervaluation</li>
</ul>
<div class="lb-trans"><ul>
<li>Zoetis 宣布新股息，暗示被低估</li>
</ul>
</div><p><strong>Check Out Our Latest Research Report on ELAN</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 ELAN 的最新研究报告</strong></p>
</div><h2>Insider Activity at Elanco Animal Health</h2>
<div class="lb-trans"><h2>Elanco Animal Health 的内部活动</h2>
</div><p>In related news, Director Lawrence Erik Kurzius acquired 10,000 shares of the stock in a transaction that occurred on Tuesday, March 11th. The stock was acquired at an average cost of $10.20 per share, for a total transaction of $102,000.00. Following the transaction, the director now directly owns 111,459 shares in the company, valued at $1,136,881.80. This trade represents a 9.86% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through this hyperlink. 0.89% of the stock is currently owned by insiders.</p>
<div class="lb-trans"><p>在相关消息中，董事 Lawrence Erik Kurzius 于 3 月 11 日星期二收购了 10,000 股该股票。该股票的平均收购成本为每股 10.20 美元，总交易额为 102,000.00 美元。交易完成后，该董事目前直接持有该公司 111,459 股股票，价值 1,136,881.80 美元。这笔交易代表了他们持股的 9.86% 增加。该交易已在与证券交易委员会的法律文件中披露，相关文件可通过此超链接获取。当前 0.89% 的股票由内部人士持有。</p>
</div><h2>Elanco Animal Health Price Performance</h2>
<div class="lb-trans"><h2>Elanco Animal Health 的价格表现</h2>
</div><ul>
<li>2 Contrarian Stock Picks With Major Upside</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只具有重大上行潜力的逆向股票推荐</li>
</ul>
</div><p>Shares of NYSE:ELAN opened at $12.68 on Friday. The firm has a 50 day moving average of $10.30 and a 200-day moving average of $11.46. Elanco Animal Health Incorporated has a 12 month low of $8.02 and a 12 month high of $18.80. The company has a current ratio of 2.55, a quick ratio of 1.31 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $6.30 billion, a PE ratio of 31.70, a PEG ratio of 2.50 and a beta of 1.49.</p>
<div class="lb-trans"><p>NYSE:ELAN 的股票在周五开盘价为 12.68 美元。该公司有 50 日移动平均线为 10.30 美元，200 日移动平均线为 11.46 美元。Elanco Animal Health Incorporated 的 12 个月低点为 8.02 美元，12 个月高点为 18.80 美元。该公司的流动比率为 2.55，速动比率为 1.31，债务与股本比率为 0.66。该股票的市值为 63 亿美元，市盈率为 31.70，市盈增长比率为 2.50，贝塔值为 1.49。</p>
</div><p>Elanco Animal Health (NYSE:ELAN - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.31 by $0.06. Elanco Animal Health had a net margin of 4.60% and a return on equity of 6.78%. The business had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same period in the previous year, the business earned $0.34 earnings per share. The company's revenue was down 1.0% on a year-over-year basis. On average, equities research analysts predict that Elanco Animal Health Incorporated will post 0.91 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Elanco Animal Health (NYSE:ELAN - 获取免费报告) 最近于 5 月 7 日宣布了其季度财报。该公司报告季度每股收益为 0.37 美元，超出市场共识预期的 0.31 美元，超出幅度为 0.06 美元。Elanco Animal Health 的净利润率为 4.60%，股本回报率为 6.78%。该公司在本季度的收入为 11.9 亿美元，而市场共识预期为 11.7 亿美元。在去年同期，该公司每股收益为 0.34 美元。该公司的收入同比下降了 1.0%。平均而言，股票研究分析师预测 Elanco Animal Health Incorporated 在当前财年将发布 0.91 美元的每股收益。</p>
</div><h2>Elanco Animal Health Profile</h2>
<div class="lb-trans"><h2>Elanco Animal Health 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands.</p>
<div class="lb-trans"><p>Elanco Animal Health Incorporated 是一家动物健康公司，创新、开发、生产和销售宠物和农场动物的产品。它提供宠物健康疾病预防产品，如驱虫剂和疫苗产品，保护宠物免受蠕虫、跳蚤和蜱虫的侵害，品牌包括 Seresto、Advantage、Advantix 和 Advocate；针对犬猫的疼痛、骨关节炎、耳部感染、心血管和皮肤病等适应症的宠物健康治疗产品，品牌包括 Galliprant 和 Claro；用于家禽和水产养殖生产的疫苗、抗生素、驱虫剂及其他产品，以及营养健康产品，包括酶、益生菌和益生元；以及用于反刍动物和猪生产的一系列疫苗、抗生素、植入物、驱虫剂及其他产品，品牌包括 Rumensin 和 Baytril。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Elanco Animal Health</li>
<li>Best ESG Stocks: 11 Best Stocks for ESG Investing</li>
<li>Turbulence for Joby Shares: What's Behind the Recent Dip?</li>
<li>CD Calculator: Certificate of Deposit Calculator</li>
<li>Why Carnival Could Be the Ultimate Non-Tech Growth Stock</li>
<li>Trading Halts Explained</li>
<li>Super Micro Computer Stock Clears New Path Higher on Saudi Orders</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而非 Elanco Animal Health</li>
<li>最佳 ESG 股票：11 只最佳 ESG 投资股票</li>
<li>Joby 股票的波动：近期下跌背后的原因是什么？</li>
<li>CD 计算器：定期存款计算器</li>
<li>为什么嘉年华可能是终极非科技增长股票</li>
<li>交易暂停解释</li>
<li>超微计算机股票因沙特订单而开辟新高的路径</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding ELAN?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elanco Animal Health Incorporated (NYSE:ELAN - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 ELAN 感兴趣的对冲基金持有什么吗？</strong> 访问 HoldingsChannel.com 获取 Elanco Animal Health Incorporated (NYSE:ELAN - 免费报告) 的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMQU4" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=ELAN"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Elanco Animal Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Elanco Animal Health 吗？</h2>
</div><p>Before you consider Elanco Animal Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Elanco Animal Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elanco Animal Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 Elanco Animal Health 并不在名单上。</p>
</div><p>While Elanco Animal Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Elanco Animal Health 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Lazard 资产管理公司购买了 Elanco Animal Health 公司（纽约证券交易所代码：ELAN）的 25,109 股股票